Evaluation of oncological safety of Magnerot on a model of lung carcinoma

Cover Page
  • Authors: Adamyan L.V1,2, Gromova O.A3, Gracheva O.N4, Kalacheva A.G3, Torshin I.Y.5, Filimonova M.V6
  • Affiliations:
    1. V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
    2. A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
    3. Ivanovo State Medical Academy of the Ministry of Health of the Russian Federation
    4. Samara State Medical University of the Ministry of Health of the Russian Federation
    5. Moscow Institute of Physics and Technology
    6. National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
  • Issue: Vol 18, No 6 (2016)
  • Pages: 98-102
  • Section: Articles
  • URL: https://journals.rcsi.science/2075-1753/article/view/94523
  • ID: 94523

Cite item

Full Text

Abstract

Compensation of prolonged magnesium deficiency is carried out with organic magnesium salts. Here, the results of experimental evaluation of the oncological safety of magnesium orotate in doses of 5 and 10 mg/kg (elemental magnesium) are presented. The high oncological safety of the Magnerot was tested on a standard model - Lewis lung carcinoma.

About the authors

L. V Adamyan

V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation; A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

акад. РАН, д-р мед. наук, проф., зам. дир. по научной работе ФГБУ НЦАГиП им. В.И.Кулакова, зав. каф. репродуктивной медицины и хирургии фак-та последипломного образования ГБОУ ВПО МГМСУ им. А.И.Евдокиомва 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4; 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

O. A Gromova

Ivanovo State Medical Academy of the Ministry of Health of the Russian Federation

Email: unesco.gromova@gmail.com
д-р мед. наук, проф. каф. фармакологии и клин. фармакологии ГБОУ ВПО ИвГМА 153462, Russian Federation, Ivanovo, pr. Sheremetevskii, d. 8

O. N Gracheva

Samara State Medical University of the Ministry of Health of the Russian Federation

канд. мед. наук, доц. каф. акушерства и гинекологии ИПО ФГБОУ ВО СамГМУ Калачева 443099, Russian Federation, Samara, ul. Chapaevskaia, d. 89

A. G Kalacheva

Ivanovo State Medical Academy of the Ministry of Health of the Russian Federation

канд. мед. наук, доц. каф. фармакологии и клин. фармакологии ГБОУ ВПО ИвГМА 153462, Russian Federation, Ivanovo, pr. Sheremetevskii, d. 8

I. Yu Torshin

Moscow Institute of Physics and Technology

канд. физ.-мат. наук, доц. каф. «Интеллектуальные системы» ФГАОУ ВПО МФТИ 141700, Russian Federation, Dolgoprudnyi, Institutskii per., d. 9

M. V Filimonova

National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

канд. мед. наук, ФГБУ НМИРЦ 249036, Russian Federation, Obninsk, ul. Koroleva, d. 4

References

  1. Громова О.А., Калачева А.Г., Торшин И.Ю. и др. Недостаточность магния - достоверный фактор риска коморбидных состояний: результаты крупномасштабного скрининга магниевого статуса в регионах России. Фарматека. 2013; 6 (259): 115-29.
  2. Torshin I.Y, Gromova O.A. Magnesium and pyridoxine: fundamental studies and clinical practice. Nova Science Publ 2011.
  3. Vasudevan S, Laconi E, Rao P.M et al. Perturbations of endogenous levels of orotic acid and carcinogenesis: effect of an arginine - deficient diet and carbamyl aspartate on hepatocarcinogenesis in the rat and the mouse. Carcinogenesis 1994; 15 (11): 2497-500.
  4. Laconi E, Denda A, Rao P.M et al. Studies on liver tumor promotion in the rat by orotic acid: dose and minimum exposure time required for dietary orotic acid to promote hepatocarcinogenesis. Carcinogenesis 1993; 14 (9): 1771-5.
  5. Walenta S, Voelxen N.F, Mueller-Klieser W. Lactate-An Integrative Mirror of Cancer Metabolism. Recent Results Cancer Res. 2016; 207: 23-37. doi: 10.1007/978- 3-319-42118-6_2.
  6. Chang C.C, Zhang C, Zhang Q et al. Upregulation of lactate dehydrogenase a by 14-33? leads to increased glycolysis critical for breast cancer initiation and progression. Oncotarget 2016; May 2. doi: 10.18632/oncotarget.9136.
  7. Romero-Garcia S, Moreno-Altamirano M.M, Prado-Garcia H, Sanchez-Garcia F.J. Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance. Front Immunol 2016; 7: 52. doi: 10.3389/fimmu.2016.00052.
  8. Guedes M, Araujo J.R, Correia-Branco A et al. Modulation of the uptake of critical nutrients by breast cancer cells by lactate: Impact on cell survival, proliferation and migration. Exp Cell Res 2016; 341 (2): 111-22. doi: 10.1016/j.yexcr.2016.01.008.
  9. Vlachostergios P.J, Oikonomou K.G, Gibilaro E, Apergis G. Elevated lactic acid is a negative prognostic factor in metastatic lung cancer. Cancer Biomark 2015; 15 (6): 725-34. doi: 10.3233/CBM-150514.
  10. Машковский М.Д. Лекарственные средства. Пособие для врачей. Справочник. 15-е изд. М.: Новая Волна, 2005.
  11. Kawano K, Hattori Y, Iwakura H et al. Adrenal tumor volume in genetically engineered mouse model of neuroblastoma determined by magnetic resonance imaging. Exp Ther Med 2012; 4 (1): 61-4.
  12. Хабриев Р.У. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. Изд. 2-е, перераб. и доп. М.: Медицина, 2005.

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies